Skip to content

Virtual Reality Confrontation with the Inner Critic

Virtual Reality Confrontation with the Inner Critic - VR-CIC

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00034488
Enrollment
40
Registered
2025-06-04
Start date
2025-06-13
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F32 F33

Interventions

Group 1: Confrontation of the personal inner critic, represented by an individualized self-avatar in a virtual reality environment and utilization of methods for cognitive defusion (method A via expos

Sponsors

Universitätsklinikum Bonn, Klinik für Psychiatrie und Psychotherapie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Diagnosed (recurrent) depressive episode Sufficent understanding of German language Current medication, psychotherapy or other S3-guideline compliant treatment for depressive disorders Normal (or corrected) vision capacity

Exclusion criteria

Exclusion criteria: Psychotic symptoms, demential symptoms, schizophrenia, epilepsy, bipolar depression, addiction disorders, severe neurological disorders, signs of severe risk for suicide

Design outcomes

Primary

MeasureTime frame
Virtual-reality sickness (VRSQ) Satisfaction with the Design (CSQ_I) Usability and acceptability of VR-Design (SUS) Personal Involvement (PII)

Secondary

MeasureTime frame
Agreement to pre-defined self-devaluating thoughts (Self-developed quest.) Cognitive Fusion (CFQ-D) Self-efficacy (WIRK-ALL) Sensory imagery (PSI-Q) Mood states (POMS) Baseline Self-other distinction (FEEB) Baseline Depression score (PHQ9) Baseline Personality traits (BFI-10)

Countries

Germany

Contacts

Public ContactTatiana Goregliad Fjaellingsdal

Universitätsklinikum Bonn,Universitätsklinikum Bonn, Klinik für Psychiatrie und Psychotherapie, VR-Labor

tatiana.goregliad-fjaellingsdal@ukbonn.de+49 228 287-0

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026